Morgan Stanley maintained an 'overweight' rating on ITC Ltd. with a target price of Rs 500, citing strong topline growth ...

Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceuticals' etrasimod in ulcerative colitis (UC) when it acquired the company earlier this year, and the gamble ...